Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03915483
Other study ID # MD021.1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 10, 2018
Est. completion date December 31, 2019

Study information

Verified date April 2019
Source German Center for Neurodegenerative Diseases (DZNE)
Contact Marlen Schmicker
Phone +49 3916724505
Email marlen.schmicker@dzne.de
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigation of how a single session of an attentional filter exercise of distractor inhibition combined with tDCS modulates cognitive functions like working memory, decision making and attentional control.


Description:

The study is designed as a between subject design with two groups defined by real or sham tDCS. The distractor inhibition exercise is conducted under either sham or real tDCS. Cognitive performance is assessed pre and post tDCS application, complemented by a short-termed follow-up on a consecutive day. Interindividual working memory capacity at baseline is taken into consideration.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 31, 2019
Est. primary completion date June 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria:

- right-handed

- aged between 18 and 30 years

- normal or corrected to normal vision

- German-speaking

Exclusion Criteria:

- dyschromatopsia

- neurological or neuropsychiatric diseases

- low seizure threshold

- neurological medication

- metal implants in the head

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transcranial direct current stimulation (tDCS)
sham or real tDCS for 10 minutes of 1.5 milliampere (mA) tDCS targeting the prefrontal and the posterior parietal cortex

Locations

Country Name City State
Germany German Center for Neurodegenerative Diseases Magdeburg Sachsen-Anhalt

Sponsors (1)

Lead Sponsor Collaborator
German Center for Neurodegenerative Diseases (DZNE)

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Performance change in computerized attentional filter exercise attentional filtering performance (in % correct), effects of distractor interference for different set sizes 45 minutes on 1st day (pre) and on consecutive day (post)
Primary Reaction change in computerized attentional filter exercise reaction times (in milliseconds), effects of distractor interference for different set sizes 45 minutes on 1st day (pre) and on consecutive day (post)
Primary Performance change in working memory and filtering performance Working memory and filtering performance (in % correct), effects of distractor interference for different set sizes 30 minutes per pre-assessment, post assessment directly after intervention and short-termed follow-up on the consecutive day
Primary Reaction change in working memory and filtering performance reaction times (in milliseconds), effects of distractor interference for different set sizes 30 minutes per pre-assessment, post assessment directly after intervention and short-termed follow-up on the consecutive day
Secondary Spatial Span computerized spatial span forward and backward 10 minutes per pre-assessment and short-termed follow-up on the consecutive day
Secondary Iowa Gambling Task Decision making performance 7 minutes per pre-assessment, post assessment directly after intervention and short-termed follow-up on the consecutive day
Secondary Trait-Anxiety Assessment of trait anxiety via State-Trait-Anxiety-Inventory on first day 2 minutes on first day
Secondary State-Anxiety Daily assessment of state anxiety via State-Trait-Anxiety-Inventory at the beginning of each testing day 2 minutes on first and consecutive day
Secondary Assessment of Sleep Quality daily questionnaire assessing subjective rating of sleep of the previous night on 5- to 7-point Likert format and open questions (subjective quality of sleep, current fatigue, duration of sleep); no total score 10 minutes on first and consecutive day
Secondary Daily Performance Questionnaires self developed questionnaire assessing subjective performance in tested paradigms (5-point Likert format); no total or sub score; Question 1: How difficult would you rate the task? (lowest (1) = very difficult; highest (5) = very easy) Question 2: Do you think your performance changed in the course of the task? (lowest (1) = strongly worsened; highest (5) = strongly improved) 5 minutes on first and consecutive day
Secondary Daily Strategy Questionnaires reporting of used strategies in tested paradigms (open questions; subjects reported in written notes); self developed questionnaire for qualitative analyses of task demands; no scores; Question: Did you use a strategy? If so, please explain shortly. 5 minutes on first and consecutive day
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1